Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibody.
暂无分享，去创建一个
Meric A. Ovacik | Genee Y. Lee | M. Junttila | Vanessa L. Clark | M. Dennis | Jihong Yang | D. Ellerman | K. Totpal | Fiona Zhong | N. Dybdal | T. Junttila | Ji Li | D. Slaga | Jennifer Johnston | R. Prell | Leah K Schutt | K. Staflin | M. Mathieu | Xiaocheng Chen | J. Low | R. Ybarra | Christina L. Zuch de Zafra | Maria Hristopoulos | Robyn Clark | Dionysos Slaga